Julie Rubinstein
Oncology
Adaptive Biotechnologies
United States of America
Biography
Ms. Rubinstein oversees our global commercial and business development efforts including strategic and financial transactions with corporate, pharma and academic partnerships, as well as clinical sales. Prior to joining Adaptive, Ms. Rubinstein has held various worldwide commercial development roles at Pfizer Oncology, Johnson & Johnson and Morgan Stanley’s Global Health Care Group. She is also the Vice-Chair of the Board for The Valerie Fund, a pediatric oncology organization in New Jersey and New York. Ms. Rubinstein holds an MBA from Harvard Business School.
Research Interest
Oncology
